Navellier & Associates Inc Inogen Inc Transaction History

Navellier & Associates Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$90.12 - $152.23 $489,621 - $827,065	-5,433 Closed	0 $0
Q4 2018 Jan 15, 2019	BUY	$112.83 - $239.74 $100,870 - $214,327	894 Added 19.7%	5,433 $675,000
Q3 2018 Nov 14, 2018	BUY	$189.1 - $282.92 $426,609 - $638,267	2,256 Added 98.82%	4,539 $1.11 Million
Q2 2018 Aug 06, 2018	SELL	$123.8 - $192.48 $4,085 - $6,351	-33 Reduced 1.42%	2,283 $425,000
Q1 2018 May 21, 2018	SELL	$114.22 - $133.22 $16,790 - $19,583	-147 Reduced 5.97%	2,316 $284,000
Q4 2017 Feb 12, 2018	SELL	$93.4 - $128.74 $4,109 - $5,664	-44 Reduced 1.76%	2,463 $293,000
Q3 2017 Nov 14, 2017	BUY	$91.08 - $104.49 $228,337 - $261,956	2,507	2,507 $238,000

143

21M

119K

149K

Ticker INGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,866,500
Market Cap $220M
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Navellier & Associates Inc with notifications on news.